Introduction. Severe maternal morbidity and mortality have increased in the USA in recent years. This trend has not been consistent across all racial groups. The reasons behind this, and the relation between preexisting conditions, pregnancyassociated disease and severe maternal morbidity/mortality, have not been fully explored. Material and methods. Annual data on delivery hospitalizations between 1993 and 2012 were obtained from the Nationwide Inpatient Sample (NIS), representing a 20% sample of hospital discharges from across the USA. Chi-square tests for trend were used to examine temporal patterns in the proportion of pregnancies affected by comorbidities as defined by the Obstetric Comorbidity Score and were stratified by maternal race. Logistic regression was used to determine the impact of temporal increases in comorbidity on severe maternal morbidity/mortality. Results. In 1993, 34.3% of pregnancies had a comorbidity score of ≥1; this significantly increased to 44.1% by 2012 (p < 0.001). Baseline differences were observed between all races (Whites 33.7%, Blacks 34.5%, Hispanics 28.0%, Asian/Pacific Islanders 28.1%). Although significant increases were observed for all races, the relative rate of change was lowest for Whites (26.1% increase) and highest for Asian/Pacific Islanders (49.1% increase). The odds of severe maternal morbidity/mortality have steadily increased over time; however, adjustment for Obstetric Comorbidity Score significantly attenuates this correlation. Conclusion. The rate of both preexisting comorbidities and pregnancy-associated disease is increasing in pregnant women in the USA and varies substantially by race. These trends provide valuable insight into the increasing complexity of pregnancy in the USA and explain a proportion of the observed increase in severe maternal morbidity/mortality.
Introduction
Severe maternal morbidity typically refers to patient safety events that occur in labor and delivery and result in either severe temporary harm or have permanent consequences; these are often viewed as "near-miss" events that could have resulted in maternal mortality (1) . While specific case definitions vary (2-4), multiple authors have
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The prevalence of comorbidities, substance-related conditions and pregnancy-related conditions increased in the USA between 1993 and 2012. The odds of severe maternal morbidity/mortality have steadily increased over time; however, adjustment for the Obstetric Comorbidity Score significantly attenuates this correlation.
ª 2017 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 97 (2018) 89-96 described a temporal increase in the incidence of severe maternal morbidity and mortality in recent years in the USA (2, 5, 6) . Between 1998 Between /1999 Between and 2008 Between /2009 , severe maternal morbidity during delivery hospitalizations increased by 75% (2) . As of 2010/2011, 163/10 000 delivery hospitalizations in the USA were complicated by severe maternal morbidity (5) . Due to the relative rarity of maternal mortality in comparison with severe maternal morbidity, it is recommended that healthcare facilities review instances of severe maternal morbidity to facilitate quality improvement (1) .
Alongside this increase in severe maternal morbidity, several demographic shifts have been documented in women of childbearing age and in obstetric practice. Deliveries by women of advanced maternal age, with preexisting chronic diseases, or multiple gestation pregnancies have increased, as has the use of cesarean delivery (2, 5, 7) . The increased prevalence of preexisting chronic disease in the obstetric population is particularly concerning, as preexisting disease has been independently associated with increased risk of maternal morbidity and mortality, even after adjustment for other demographic shifts (8, 9) .
The increase in maternal mortality has not been consistent across all racial groups. The Black-White disparity in maternal mortality has increased over time (10) ; as of 2010, the maternal mortality rate for Black women was over three times that observed for White women at 38.9 vs. 12.0 deaths/100 000 live births (11) . Data from the Pregnancy Mortality Surveillance System suggest that this excess mortality in Black women is due to higher case fatality rates, as opposed to higher incidence rates of severe maternal morbidity (12) . Multiple hypotheses have been proposed to explain the increased case fatality rate in Black women related to both patient and health system characteristics; however, the role of preexisting disease in explaining the increased case fatality rate in Black women has not been systematically explored. While health disparities between other racial groups have been less frequently explored, Hispanic [odds ratio (OR) = 1.3, 95% confidence interval (CI) 1.2-1.3], Asian/Pacific Islander (OR = 1.2, 95% CI 1.2-1.3), and American Indian/Alaska Native (OR = 1.7, 95% CI 1.5-1.8) women all have significantly higher rates of severe maternal morbidity than those of White women (13) . Again, the role of differing patterns of preexisting and pregnancy-associated disease in these groups has not been fully explored.
We aimed to describe the temporal pattern of comorbidity, overall and stratified by race, in an obstetric population and quantify the impact of temporal patterns of comorbidity on the rising incidence of severe maternal morbidity and mortality in the USA.
Material and methods
Population-based data on delivery hospitalizations in the USA from 1993 to 2012 were obtained from the Nationwide Inpatient Sample (NIS) from the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality (AHRQ) (14) . The NIS contains data on a 20% stratified sample of all hospital discharges from hospitals in the USA. Each de-identified record contains information on patient demographics, diagnoses, procedures, length of stay, and hospital characteristics (14) . The NIS data is audited annually prior to public release to ensure data quality and integrity (14) .
This study involved all delivery hospitalizations among women aged 10-55 between 1993 and 2012 recorded in the NIS data. Deliveries occurring for women <10 or >55 years of age were excluded to minimize the impact of extremes of maternal age. Validated algorithms were used to define delivery hospitalizations (15) , comorbidity (16, 17) , and severe maternal morbidity (2) using International Classification of Disease Version 9 -Clinical Modification (ICD9-CM) codes. Specifically, the enhanced algorithm to identify obstetric deliveries developed by Kuklina et al. (15) was used to identify women who were hospitalized for obstetric delivery (15) . This hierarchical algorithm uses a combination of ICD9-CM diagnostic codes related to the outcome of delivery, ICD9-CM procedure codes for delivery-related procedures, and diagnosis-related group (DRG) codes related to obstetric deliveries to identify women who delivered a live or stillborn infant (15) . This enhanced algorithm identifies more deliveries than relying on diagnostic codes alone, particularly deliveries associated with maternal and infant complications (15) . Comorbidities were identified using the Obstetric Comorbidity Score (16) . The Obstetric Comorbidity Score is a weighted algorithm that assigns points for the presence of preexisting comorbidities, substancerelated conditions, pregnancy-related conditions, and advanced maternal age (≥35 years), with higher scores corresponding to worse health status (16) . For example, a 37-year-old woman (1 point) with preexisting diabetes (1 point) and a singleton pregnancy (0 points) would have a total score of 2 points, whereas a 29-year-old woman (0 points) with a multiple gestation pregnancy (2 points) and severe preeclampsia (5 points) would have a total score of 7 points. This score was originally developed to predict end-organ damage or death (16) ; further validation work has also confirmed its predictive ability for maternal end-organ damage and identified its ability to predict prolonged length of hospital stay (17) . While originally designed for use with data on the entire obstetric course (16) , its predictive ability when data is restricted to the time of delivery has also been confirmed (17) . Severe maternal morbidity was defined using the Centers for Disease Control and Prevention algorithm (2) . This case definition identifies ICD9-CM diagnostic and procedure codes associated with severe complications related to childbirth (2) . Maternal mortality was assessed using a death in hospital indicator flag.
Proportions (with 95% CI) were used to report population demographic characteristics and to determine the prevalence of comorbidity overall and stratified by maternal race. Rates of comorbidity were further broken down by sub-type as per categories defined within the Obstetric Comorbidity Score (i.e. maternal age, preexisting conditions, substance-related conditions, and pregnancy-associated conditions). The p-values for trend were used to examine temporal trends over the 20-year period grouped in five-year epochs, and the absolute percent change between 1993 and 2012 was used to examine the absolute change over time. Logistic regression was used to evaluate the temporal association between severe maternal morbidity/mortality and comorbidity score. A crude model was used initially to examine the association between time and severe maternal morbidity and mortality. Adjusted models were then developed to control for the impact of comorbidity (measured by the Obstetric Comorbidity Score) and maternal race. Odds ratios and corresponding 95% CI were used as the measure of association. Sensitivity analyses were performed looking at severe maternal morbidity or maternal morality independently, and at the individual components of severe maternal morbidity. All analyses were conducted using STATA 11 MP (Stata Corp., College Station, TX, USA).
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Results
Between 1993 and 2012, 12 776 167 women met all inclusion criteria, of which 2.3% experienced a severe maternal morbidity or died in hospital. As observed in other studies, the rate and the absolute numbers of maternal inhospital deaths increased over time. Although only a small change was observed in the rate of in-hospital maternal mortality (0. Temporal shifts in population demographics were observed (Table 1) . Between 1993 and 2012, the proportion of births to women between the ages of 35 and 44 increased, while births to women 45 years of age and older decreased. The prevalence of preexisting comorbidities, substance-related conditions and pregnancy-related conditions all increased. The largest absolute increase was in the proportion of women with pregnancy-associated conditions (i.e. preeclampsia, placenta previa), which increased from 17.8% in 1993-1997 to 24.5% in 2008-2012. Both the increase in comorbidities and maternal age contributed to a lower proportion of deliveries to women with an Obstetric Comorbidity Score of zero.
The net increase in comorbidities was not uniform across racial groups (Table 2) As seen in Figure 1 , the odds of severe maternal morbidity/mortality decrease from epoch 1 to 2 and then steadily increase over time. This pattern is observed for some elements of severe maternal morbidity -namely, sepsis, shock, puerperal cerebrovascular disorders, and internal injuries of thorax, abdomen and pelvis (Supporting Information Table S1 ). However, adjustment for the Obstetric Comorbidity Score significantly attenuates these relationships. Adjustment for the Obstetric Comorbidity Score reduces the odds ratio for severe maternal morbidity or morality in 2008-2012 from 1.68 (95% CI 1.66-1.70) to 1.37 (95% CI 1.35-1.38). Further adjustment for maternal race did not result in appreciable differences. Sensitivity analyses examining severe maternal morbidity or maternal mortality separately found similar results for the elements of severe maternal morbidity that increased over time; however, for elements where a temporal decrease was present (i.e. pulmonary edema, severe anesthesia complications), adjustment for the Obstetric Comorbidity Score further decreased the effect estimates, resulting in a stronger temporal association (Table S1 ).
Discussion
This study shows the impact of changing demographic patterns on health outcomes among pregnant women in the USA. Not only are women more likely to enter pregnancy with a preexisting chronic disease, they are also more likely to develop a pregnancy-associated disease. In 2008-2012, 43% of women had a preexisting chronic disease, developed a pregnancy-associated disease, or were of advanced maternal age; this represents a 23.5% increase since 1993-1997. Other studies have investigated temporal changes in severe maternal morbidity and mortality, but our study provides a unique contribution to the field by examining the relative contribution of comorbidity (both preexisting and pregnancy-associated conditions) to these temporal trends. Maternal health status before pregnancy is an important contributor to obstetric outcomes. Importantly, even for elements of severe maternal morbidity that have been decreasing in frequency over time, changing patterns of comorbidity in the obstetric population still appear to influence these outcomes, indicating that additional decreases may still be possible if women entered pregnancy in a healthier state.
With the increased prevalence of chronic disease in an obstetric population, the development of standardized disease-specific protocols may improve outcomes in this population. For example, after implementing a policy involving the automatic dispensation of antihypertensive medication for patients exceeding blood pressure thresholds, this significantly reduced the incidence of maternal mortality associated with preeclampsia in the Hospital Corporation of America facilities (18) . However, simply addressing preexisting medical conditions at the time of delivery is unlikely to be sufficient to prevent severe maternal morbidity and mortality. Approximately half of pregnancies in the USA are unplanned, and maternal mortality review committees frequently report that many women who died during their pregnancies, or shortly thereafter, had poorly managed chronic conditions prior to pregnancy and were not provided with a coordinated and comprehensive management strategy to optimize control of their chronic disease after pregnancy (19) . Pregnancy is a time where women have frequent contact with the healthcare system and are motivated to make lifestyle changes. This creates an opportunity for healthcare providers to implement changes that will influence both women's pregnancy outcomes and their long-term health status. The racial disparities in the prevalence of preexisting chronic disease and pregnancy-associated disease observed in this study are troubling, but understanding the role that racial disparities in preconception health play in the incidence of severe maternal morbidity and mortality is an important first step that may ultimately lead to the development of targeted interventions. In this study, we found that the Black-White disparity in the prevalence of preexisting chronic disease has increased over time. Other authors have also noted the Black women are more likely to have a delayed entry into prenatal care (12) . This speaks to the need for a comprehensive assessment of maternal health (beyond reproductive health) to occur both at the first prenatal visit, whenever that occurs, and at the six-week postpartum visit to ensure that appropriate referrals and interventions are offered to optimize the management of preexisting conditions and to ensure that pregnancy-associated conditions have resolved and are not merely late diagnoses of preexisting conditions. However, as a recent American study using data from a managed care organization suggests that approximately half of women fail to attend their scheduled postpartum visit (20) , it is important not to delay referrals to other services until the postpartum period.
In a recent editorial, Hardemann et al. (21) discuss the negative impact that structural racism in the American health care system has on population health. While not conventionally viewed as in the domain of healthcare providers, a push towards identifying and addressing structural racism in the healthcare system and creating opportunities for traditionally under-represented groups to achieve positions of power may have the biggest impact on reducing racial disparities in severe maternal morbidity and mortality. Differences in care by race have been reported in the literature. After adjustment for patient characteristics, Black, Asian and Hispanic women are less likely to have their labor induced compared with their White counterparts (22) . Additionally, women from different racial groups tend to deliver in different hospital environments which may also in part explain racial disparities in outcomes. For example, both Hispanic (23) and Black (24) women in the USA tend to deliver in hospitals with higher rates of severe maternal morbidity and lower quality of care. A simulation study estimated that the Hispanic-White disparity in severe maternal morbidity could be reduced by 54% if Hispanic women delivered in hospitals with severe maternal morbidity rates comparable to those observed in primarily White-serving hospitals (23) .
This study has both strengths and limitations. The large sample size and population-based sampling used in the NIS ensure the generalizability of our findings to the broader population of pregnant women in the USA. Although administrative data have been validated in obstetric populations and found to be an accurate source of diagnoses and procedures (25) (26) (27) , the data contain no information on the severity of the conditions or information on how it was treated outside of the hospital. As the NIS data are not linkable across multiple hospitalizations for the same individual, no data are available on past obstetric history or other non-medical variables that may contribute to severe maternal morbidity or mortality, such as socioeconomic status, smoking status, linguistic isolation, or quality of the patient-provider relationship. Additionally, not all forms of severe maternal morbidity (for instance placenta accreta) or obstetric risk factors (for example obesity) were evaluated in our composite outcomes, and therefore we are unable to comment on whether the incidence of these conditions has changed over time or differs by racial groups. We have also underestimated maternal mortality, as the NIS only captures data on in-hospital deaths. A comprehensive review of maternal mortality in the USA found that only 16.6% of pregnant women died on the day of delivery or pregnancy termination (11). While we have used validated case definitions to measure both exposure and outcome, misclassification is still possible.
In conclusion, the proportion of pregnant women with preexisting chronic disease or who develop a pregnancyassociated disease increased significantly in the USA from 1993 to 2012. This change in health status is partly responsible for the temporal increase in severe maternal morbidity and mortality. Obstetrical care providers have a unique opportunity to engage women in care and optimize the management of chronic disease. Coordinated and comprehensive management of preexisting chronic disease and appropriate follow up postpartum may result in improved health outcomes for women and their children.
